{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T12:07:53Z","timestamp":1769602073886,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bristol Myers Squibb"},{"DOI":"10.13039\/100009947","name":"Merck Sharp & Dohme","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Novartis"},{"DOI":"10.13039\/100013226","name":"Les Laboratories Pierre Fabre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although the largest increase in melanoma incidence is observed for localised melanoma, little research has been done on its impact. Despite favourable prognoses and relatively short treatment trajectories, diagnosis and treatment may significantly impact life post-treatment. Therefore, the aim of this study was to gain an in-depth understanding of stage I and II melanoma survivors\u2019 experiences resuming life after treatment and their associated survivorship care (SSC) needs. A qualitative focus group study was conducted with 18 stage I or II melanoma survivors, divided over three focus groups with 6 survivors each. Transcripts were analysed through thorough thematic content analysis, using multiple phases of coding. In resuming life, survivors experienced profound initial impacts of disease and treatment, fed by a perceived lack of knowledge and underestimation of melanoma. They faced unexpected physical and emotional effects post-surgery, experiencing mixed feelings from relief to fear and uncertainty. Survivors felt misunderstood, had to adjust their lives, and managed personal and external expectations while experiencing a positive shift in life perspective, leading to a notable difference in life before and after cancer. In terms of SSC needs, survivors stressed the need for tailored information, accessible resources, patient-centered follow-up, and supportive care addressing the total impact of disease and treatment. These findings highlight the importance of improving melanoma awareness and providing holistic SSC not only to advanced, but also to localised melanoma survivors. A tailored survivorship care plan could facilitate access to information and supportive care, helping patients resume their lives.<\/jats:p>","DOI":"10.1007\/s00403-024-03376-4","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T13:02:29Z","timestamp":1727355749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201cThere is a life before and after cancer\u201d: experiences of resuming life and unmet care needs in stage I and II melanoma survivors"],"prefix":"10.1007","volume":"316","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8386-2540","authenticated-orcid":false,"given":"N. C.W.","family":"Kamminga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. E.C.","family":"Kievits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8578-901X","authenticated-orcid":false,"given":"M.","family":"Wakkee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2255-4184","authenticated-orcid":false,"given":"S. G.W. van","family":"Loon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5064-7302","authenticated-orcid":false,"given":"M. C.W.","family":"Joosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Verver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3338-0786","authenticated-orcid":false,"given":"K.","family":"Munte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0501-813X","authenticated-orcid":false,"given":"P. W.P.","family":"Plaisier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0538-5603","authenticated-orcid":false,"given":"J. A.C.","family":"Rietjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9940-2875","authenticated-orcid":false,"given":"T. E.C.","family":"Nijsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4117-2154","authenticated-orcid":false,"given":"M.","family":"Lugtenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"3376_CR1","unstructured":"Cancer TODAY | IARC - https:\/\/gco.iarc.who.int. Data version: Globocan 2022 (version 1.1) \u2013\u200908.02.2024: International Agency for Research on Cancer. World Health Organization.; [ https:\/\/gco.iarc.fr\/today\/en\/dataviz\/pie?mode=population&group_populations=0&cancers=16"},{"key":"3376_CR2","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ejca.2021.06.007","volume":"154","author":"B Leeneman","year":"2021","unstructured":"Leeneman B, Schreuder K, Uyl-de Groot CA, van Akkooi ACJ, Haanen J, Wakkee M et al (2021) Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003\u20132018): a nationwide population-based study. Eur J Cancer 154:111\u2013119","journal-title":"Eur J Cancer"},{"issue":"8","key":"3376_CR3","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1080\/14737140.2018.1489246","volume":"18","author":"EZ Keung","year":"2018","unstructured":"Keung EZ, Gershenwald JE (2018) The eighth edition American Joint Committee on Cancer (AJCC) melanoma staging system: implications for melanoma treatment and care. Expert Rev Anticancer Ther 18(8):775\u2013784","journal-title":"Expert Rev Anticancer Ther"},{"key":"3376_CR4","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.ejca.2022.03.008","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al (2022) European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022. Eur J Cancer 170:236\u2013255","journal-title":"Eur J Cancer"},{"key":"3376_CR5","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ejca.2022.04.018","volume":"170","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N et al (2022) European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment - update 2022. Eur J Cancer 170:256\u2013284","journal-title":"Eur J Cancer"},{"issue":"6","key":"3376_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3322\/caac.21409","volume":"67","author":"JE Gershenwald","year":"2017","unstructured":"Gershenwald JE, Scolyer RA, Hess KR, Sondak VK, Long GV, Ross MI et al (2017) Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 67(6):472\u2013492","journal-title":"CA Cancer J Clin"},{"key":"3376_CR7","doi-asserted-by":"crossref","unstructured":"van der Kamminga NCW, Joosen MCW, de Joode K, Joosse A, Grunhagen DJ et al (2022) Experiences of resuling life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma. Br J Dermatol","DOI":"10.1111\/bjd.21670"},{"issue":"11","key":"3376_CR8","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1002\/pon.4290","volume":"26","author":"J Dunn","year":"2017","unstructured":"Dunn J, Watson M, Aitken JF, Hyde MK (2017) Systematic review of psychosocial outcomes for patients with advanced melanoma. Psychooncology 26(11):1722\u20131731","journal-title":"Psychooncology"},{"issue":"3","key":"3376_CR9","doi-asserted-by":"publisher","first-page":"e024450","DOI":"10.1136\/bmjopen-2018-024450","volume":"9","author":"HM Buiting","year":"2019","unstructured":"Buiting HM, van Ark MAC, Dethmers O, Maats EPE, Stoker JA, Sonke GS (2019) Complex challenges for patients with protracted incurable cancer: an ethnographic study in a comprehensive cancer centre in the Netherlands. BMJ Open 9(3):e024450","journal-title":"BMJ Open"},{"issue":"4","key":"3376_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s00520-024-08398-2","volume":"32","author":"LC van der Zwanenburg","year":"2024","unstructured":"Zwanenburg LC, van der Lee ML, Koldenhof JJ, Suijkerbuijk KPM, Schellekens MPJ (2024) What patients with advanced cancer experience as helpful in navigating their life with a long-term response: a qualitative study. Support Care Cancer 32(4):222. https:\/\/doi.org\/10.1007\/s00520-024-08398-2. PMID: 38470541.","journal-title":"Support Care Cancer"},{"key":"3376_CR11","doi-asserted-by":"crossref","unstructured":"Raducu L, Avino A, Purnichescu Purtan R, Balcangiu-Stroescu AE, Balan DG, Timofte D et al (2020) Quality of life in patients with surgically removed skin tumors. Med (Kaunas). ;56(2)","DOI":"10.3390\/medicina56020066"},{"key":"3376_CR12","doi-asserted-by":"crossref","unstructured":"Mahama AN, Haller CN, Labrada J, Idiong CI, Haynes AB, Jacobs EA et al (2024) Lived experiences and fear of Cancer Recurrence among survivors of localized cutaneous melanoma. JAMA Dermatol","DOI":"10.1001\/jamadermatol.2023.6158"},{"issue":"11","key":"3376_CR13","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1111\/j.1468-3083.2011.04297.x","volume":"26","author":"C van de Holterhues","year":"2012","unstructured":"van de Holterhues C, de Vries E, Neumann HA, Nijsten TE (2012) Melanoma patients receive more follow-up care than current guideline recommendations: a study of 546 patients from the general Dutch population. J Eur Acad Dermatol Venereol 26(11):1389\u20131395","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3376_CR14","unstructured":"Hewitt M, Greenfield S, Stovall E (2005) Lost in transition. From cancer patient to cancer survivor. :1\u2013506"},{"issue":"1","key":"3376_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/bjd.19868","volume":"185","author":"ZJ Wolner","year":"2021","unstructured":"Wolner ZJ, Flowers NI, Yushak ML, Chen SC, Yeung H (2021) Exploring the melanoma survivorship experience: a qualitative study. Br J Dermatol 185(1):221\u2013223","journal-title":"Br J Dermatol"},{"issue":"1","key":"3376_CR16","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1186\/s12885-023-10759-9","volume":"23","author":"NCW Kamminga","year":"2023","unstructured":"Kamminga NCW, Wakkee M, De Bruin RJ, Joosse A, Reeder SWI et al (2023) Oncological healthcare providers\u2019 perspectives on appropriate melanoma survivorship care: a qualitative focus group study. BMC Cancer 23(1):278","journal-title":"BMC Cancer"},{"issue":"4","key":"3376_CR17","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1365-2133.2010.09895.x","volume":"163","author":"O Husson","year":"2010","unstructured":"Husson O, Holterhues C, Mols F, van de Nijsten T (2010) Melanoma survivors are dissatisfied with perceived information about their diagnosis, treatment and follow-up care. Br J Dermatol 163(4):879\u2013881","journal-title":"Br J Dermatol"},{"key":"3376_CR18","unstructured":"Green J, Thorogood N (2018) Qualitative methodology in health research. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd"},{"issue":"2","key":"3376_CR19","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jid.2020.11.029","volume":"141","author":"A Bazen","year":"2021","unstructured":"Bazen A, Barg FK, Takeshita J (2021) Research Techniques made simple: an introduction to qualitative research. J Invest Dermatol 141(2):241\u20137e1","journal-title":"J Invest Dermatol"},{"key":"3376_CR20","unstructured":"Green J, Thorogood N (2018) Group interviews and discussions. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd"},{"issue":"9","key":"3376_CR21","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1097\/ACM.0000000000000388","volume":"89","author":"BC O\u2019Brien","year":"2014","unstructured":"O\u2019Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA (2014) Standards for reporting qualitative research: a synthesis of recommendations. Acad Med 89(9):1245\u20131251","journal-title":"Acad Med"},{"key":"3376_CR22","volume-title":"Keywords in qualitative methods: purposive sampling. Qualitative evaluation and research methods","author":"M Bloor","year":"2016","unstructured":"Bloor M, Wood F (2016) Keywords in qualitative methods: purposive sampling. Qualitative evaluation and research methods, 2nd edn. SAGE, Newbury Park, CA","edition":"2"},{"issue":"4","key":"3376_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/1049732316665344","volume":"27","author":"MM Hennink","year":"2017","unstructured":"Hennink MM, Kaiser BN, Marconi VC (2017) Code saturation versus meaning saturation: how many interviews are Enough? Qual Health Res 27(4):591\u2013608","journal-title":"Qual Health Res"},{"issue":"5","key":"3376_CR24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1002\/cncr.31844","volume":"125","author":"BH de Rooij","year":"2019","unstructured":"de Rooij BH, Ezendam NPM, Vos MC, Pijnenborg JMA, Boll D, Kruitwagen R et al (2019) Patients\u2019 information coping styles influence the benefit of a survivorship care plan in the ROGY Care Trial: new insights for tailored delivery. Cancer 125(5):788\u2013797","journal-title":"Cancer"},{"key":"3376_CR25","unstructured":"Green J, Thorogood N (2018) Developing qualitative analysis. Qualitative methods for health research. Fourth edition. London: SAGE Publications Ltd"},{"key":"3376_CR26","volume-title":"The discovery of grounded theory: strategies for qualitative research","author":"B Glaser","year":"1967","unstructured":"Glaser B, Strauss A (1967) The discovery of grounded theory: strategies for qualitative research. Aldine, Chicago"},{"key":"3376_CR27","first-page":"114","volume-title":"The SAGE encyclopedia of qualitative research methods. 2. Los Angeles","year":"2008","unstructured":"Constant Comparison. In (2008) In: Given LM (ed) The SAGE encyclopedia of qualitative research methods. 2. Los Angeles. SAGE, Calif, pp 114\u2013115"},{"issue":"1","key":"3376_CR28","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s12895-017-0055-8","volume":"17","author":"A Kelati","year":"2017","unstructured":"Kelati A, Baybay H, Atassi M, Elfakir S, Gallouj S, Meziane M et al (2017) Skin cancer knowledge and attitudes in the region of Fez, Morocco: a cross-sectional study. BMC Dermatol 17(1):2","journal-title":"BMC Dermatol"},{"issue":"1","key":"3376_CR29","doi-asserted-by":"publisher","first-page":"e12083","DOI":"10.1002\/1348-9585.12083","volume":"62","author":"M Rocholl","year":"2020","unstructured":"Rocholl M, Ludewig M, John SM, Bitzer EM, Wilke A (2020) Outdoor workers\u2019 perceptions of skin cancer risk and attitudes to sun-protective measures: a qualitative study. J Occup Health 62(1):e12083","journal-title":"J Occup Health"},{"issue":"2","key":"3376_CR30","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jaad.2013.10.030","volume":"70","author":"DZ Korta","year":"2014","unstructured":"Korta DZ, Saggar V, Wu TP, Sanchez M (2014) Racial differences in skin cancer awareness and surveillance practices at a public hospital dermatology clinic. J Am Acad Dermatol 70(2):312\u2013317","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"3376_CR31","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.pec.2014.03.008","volume":"95","author":"MN Verkissen","year":"2014","unstructured":"Verkissen MN, Ezendam NP, Fransen MP, Essink-Bot ML, Aarts MJ, Nicolaije KA et al (2014) The role of health literacy in perceived information provision and satisfaction among women with ovarian tumors: a study from the population-based PROFILES registry. Patient Educ Couns 95(3):421\u2013428","journal-title":"Patient Educ Couns"},{"issue":"2","key":"3376_CR32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1200\/JCO.2007.13.0609","volume":"26","author":"S Gabrijel","year":"2008","unstructured":"Gabrijel S, Grize L, Helfenstein E, Brutsche M, Grossman P, Tamm M et al (2008) Receiving the diagnosis of lung cancer: patient recall of information and satisfaction with physician communication. J Clin Oncol 26(2):297\u2013302","journal-title":"J Clin Oncol"},{"issue":"2","key":"3376_CR33","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1080\/0284186X.2018.1512156","volume":"58","author":"MH Nguyen","year":"2019","unstructured":"Nguyen MH, Smets EMA, Bol N, Bronner MB, Tytgat K, Loos EF et al (2019) Fear and forget: how anxiety impacts information recall in newly diagnosed cancer patients visiting a fast-track clinic. Acta Oncol 58(2):182\u2013188","journal-title":"Acta Oncol"},{"issue":"1","key":"3376_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s41927-022-00283-x","volume":"6","author":"MM Bakker","year":"2022","unstructured":"Bakker MM, Luttikhuis T, Putrik P, Jansen I, Rademakers J, de Wit M et al (2022) Consideration of health literacy in patient information: a mixed-methods study of COVID-19 crisis communication in Dutch rheumatology. BMC Rheumatol 6(1):52","journal-title":"BMC Rheumatol"},{"issue":"12","key":"3376_CR35","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1007\/s12094-023-03214-5","volume":"25","author":"A Rodriguez-Gonzalez","year":"2023","unstructured":"Rodriguez-Gonzalez A, Carmona-Bayonas A, Hernandez San Gil R, Cruz-Castellanos P, Antonanzas-Basa M, Lorente-Estelles D et al (2023) Impact of systemic cancer treatment on quality of life and mental well-being: a comparative analysis of patients with localized and advanced cancer. Clin Transl Oncol 25(12):3492\u20133500","journal-title":"Clin Transl Oncol"},{"issue":"6","key":"3376_CR36","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.eururo.2017.06.035","volume":"72","author":"M Lardas","year":"2017","unstructured":"Lardas M, van den Liew M, De Santis M, Van den Bellmunt J et al (2017) Quality of life outcomes after primary treatment for clinically localised prostate Cancer: a systematic review. Eur Urol 72(6):869\u2013885","journal-title":"Eur Urol"},{"issue":"9","key":"3376_CR37","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1007\/s00520-022-07133-z","volume":"30","author":"I Fraterman","year":"2022","unstructured":"Fraterman I, Glaser SLC, Wilgenhof S, Medlock SK, Mallo HA, Cornet R et al (2022) Exploring supportive care and information needs through a proposed eHealth application among melanoma patients undergoing systemic therapy: a qualitative study. Support Care Cancer 30(9):7249\u20137260","journal-title":"Support Care Cancer"},{"issue":"8","key":"3376_CR38","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jamadermatol.2019.0434","volume":"155","author":"M Dieng","year":"2019","unstructured":"Dieng M, Smit AK, Hersch J, Morton RL, Cust AE, Irwig L et al (2019) Patients\u2019 views about skin self-examination after treatment for localized Melanoma. JAMA Dermatol 155(8):914\u2013921","journal-title":"JAMA Dermatol"},{"issue":"1","key":"3376_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/jamadermatol.2021.4704","volume":"158","author":"DM Ackermann","year":"2022","unstructured":"Ackermann DM, Dieng M, Medcalf E, Jenkins MC, van Kemenade CH, Janda M et al (2022) Assessing the potential for patient-led Surveillance after treatment of localized melanoma (MEL-SELF): a pilot randomized clinical trial. JAMA Dermatol 158(1):33\u201342","journal-title":"JAMA Dermatol"},{"issue":"32","key":"3376_CR40","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1200\/JCO.22.00202","volume":"40","author":"C Garbe","year":"2022","unstructured":"Garbe C, Keim U, Amaral T, Berking C, Eigentler TK, Flatz L et al (2022) Prognosis of patients with primary Melanoma Stage I and II according to American Joint Committee on Cancer Version 8 validated in two independent cohorts: implications for adjuvant treatment. J Clin Oncol 40(32):3741\u20133749","journal-title":"J Clin Oncol"}],"updated-by":[{"DOI":"10.1007\/s00403-024-03537-5","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000}}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03376-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03376-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:14:29Z","timestamp":1732608869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03376-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":40,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["3376"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03376-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00403-024-03537-5","asserted-by":"object"}]},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,26]]},"assertion":[{"value":"19 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct Reference 10.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00403-024-03537-5","URL":"https:\/\/doi.org\/10.1007\/s00403-024-03537-5","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Medical Ethics Committee Erasmus MC concluded after review of the study design that the rules laid down in the Medical Research Involving Human Subjects Act (Dutch abbreviation: WMO) did not apply to this study (MEC-2019-0558 and MEC-2020-0197).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"645"}}